# A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.

> **NCT00261560** · PHASE4 · COMPLETED · sponsor: **Johnson & Johnson Consumer and Personal Products Worldwide** · enrollment: 260 (actual)

## Conditions studied

- Sprains and Strains
- Pain

## Interventions

- **DRUG:** acetaminophen

## Key facts

- **NCT ID:** NCT00261560
- **Lead sponsor:** Johnson & Johnson Consumer and Personal Products Worldwide
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2011-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261560, "A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00261560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*